Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
Zejula
.
Show all posts
Showing posts with label
Zejula
.
Show all posts
Wednesday, March 29, 2017
FDA Approves PARP inhibitor Zejula for treatment of recurrent ovarian cancer.
›
courtesy: www.multivu.com The U.S.Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment of epit...
›
Home
View web version
